Mayinglong Pharmaceutical Group Co., Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2026 is -1.28% vs -1.64% in Mar 2026",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2026 is -28.00% vs 153.53% in Mar 2026",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'26",
        "Mar'26",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "999.40",
          "val2": "1,012.40",
          "chgp": "-1.28%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "188.90",
          "val2": "260.30",
          "chgp": "-27.43%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "1.00",
          "val2": "1.10",
          "chgp": "-9.09%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "9.60",
          "val2": "4.30",
          "chgp": "123.26%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "157.90",
          "val2": "219.30",
          "chgp": "-28.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "166.30%",
          "val2": "234.80%",
          "chgp": "-6.85%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 3.79% vs 18.93% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is 10.47% vs 21.36% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "3,842.00",
          "val2": "3,701.70",
          "chgp": "3.79%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "744.90",
          "val2": "674.70",
          "chgp": "10.40%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "13.60",
          "val2": "15.00",
          "chgp": "-9.33%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-7.60",
          "val2": "-11.80",
          "chgp": "35.59%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "605.70",
          "val2": "548.30",
          "chgp": "10.47%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "168.30%",
          "val2": "158.90%",
          "chgp": "0.94%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Jun'26 - QoQ

Jun'26

Mar'26

Change(%)

Net Sales

999.40

1,012.40

-1.28%

Operating Profit (PBDIT) excl Other Income

188.90

260.30

-27.43%

Interest

1.00

1.10

-9.09%

Exceptional Items

9.60

4.30

123.26%

Consolidate Net Profit

157.90

219.30

-28.00%

Operating Profit Margin (Excl OI)

166.30%

234.80%

-6.85%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Jun 2026 is -1.28% vs -1.64% in Mar 2026

Consolidated Net Profit

QoQ Growth in quarter ended Jun 2026 is -28.00% vs 153.53% in Mar 2026

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

3,842.00

3,701.70

3.79%

Operating Profit (PBDIT) excl Other Income

744.90

674.70

10.40%

Interest

13.60

15.00

-9.33%

Exceptional Items

-7.60

-11.80

35.59%

Consolidate Net Profit

605.70

548.30

10.47%

Operating Profit Margin (Excl OI)

168.30%

158.90%

0.94%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is 3.79% vs 18.93% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is 10.47% vs 21.36% in Dec 2024

All Annual Results